LakeShore Biopharma CoLSBCF 5-Year ROIIC % is 0.00 as of Mar. 2025. Among 1,178 Biotechnology companies, LakeShore Biopharma Co ranks worse than 84889.56% on this metric.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
LakeShore Biopharma Co does not have enough data to calculate 5-Year ROIIC %.
LakeShore Biopharma Co (OTCPK:LSBCF) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
LakeShore Biopharma Co 5-Year ROIIC % Related Terms
LakeShore Biopharma Co 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for LakeShore Biopharma Co's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSBCF vs ACUT, PPCB, ENSC: 5-Year ROIIC % Comparison
For the Biotechnology subindustry, LakeShore Biopharma Co's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LakeShore Biopharma Co 5-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where LakeShore Biopharma Co's 5-Year ROIIC % falls into.
LakeShore Biopharma Co's 5-Year ROIIC % for the quarter that ended in Mar. 2025 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( -6.0743592 (Mar. 2025) - (Mar. 2020) )
/
( 140.384 (Mar. 2025) - (Mar. 2020) )
=
/
=
N/A%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
LakeShore Biopharma Co (LSBCF) has a 5-Year ROIIC % of 0.00 as of Mar. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on LakeShore Biopharma Co and its competitors. According to the industry distribution chart, LakeShore Biopharma Co ranks #999999 out of 1178 companies in the Biotechnology industry.
Is LakeShore Biopharma Co's 5-Year ROIIC % too high?
LakeShore Biopharma Co's current 5-Year ROIIC % is 0.00. Based on the distribution chart, LakeShore Biopharma Co ranks #999999 out of 1178 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does LakeShore Biopharma Co's 5-Year ROIIC % compare to ACUT and PPCB?
According to the Biotechnology industry distribution chart, LakeShore Biopharma Co ranks #999999 out of 1178 companies for 5-Year ROIIC %. This places LakeShore Biopharma Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Biotechnology company?
A good 5-Year ROIIC % depends on the Biotechnology industry context. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current 5-Year ROIIC % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current 5-Year ROIIC % of 0.00. The current 5-Year ROIIC % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current 5-Year ROIIC % is 0.00 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSBCF has been successfully added to your 